Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, April 19, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
FDA Approves Neurelis’ VALTOCO Nasal Spray for Seizure Clusters in Children as Young as 2
Life Sciences Times
-
April 16, 2025
Pharma
MindMed Doses First Patient in Phase 3 Trial of LSD-Based Therapy for Major Depressive Disorder
Life Sciences Times
-
April 15, 2025
Pharma
Scipher Medicine and Kythera Labs Join Forces to Advance Precision Treatment for Autoimmune Diseases
Life Sciences Times
-
April 15, 2025
Pharma
Pfizer Halts Development of Oral Weight Loss Drug Danuglipron
Life Sciences Times
-
April 14, 2025
Pharma
Pheast Therapeutics Begins Phase 1 Trial of Macrophage Checkpoint Inhibitor PHST001 for Advanced Solid Tumors
Life Sciences Times
-
April 14, 2025
Pharma
Sage Therapeutics and Biogen Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive...
Life Sciences Times
-
February 6, 2023
0
Pharma
The Access to Advanced Health Institute Announces $9.9M Award to Develop a Nasal Spray Influenza RNA Vaccine Through Phase 1 Clinical Trials
Life Sciences Times
-
February 6, 2023
0
Pharma
TEZSPIRE® approved for self-administration in the US with a new pre-filled pen
Life Sciences Times
-
February 2, 2023
0
Pharma
Ellipses Pharma Announces FDA Approval of IND Application for EP0042 for Patients With Acute Myeloid Leukaemia
Life Sciences Times
-
February 1, 2023
0
Pharma
Virpax Pharmaceuticals Engages New England Investors to Direct Licensing Strategy for Envelta™ in China
Life Sciences Times
-
January 31, 2023
0
Pharma
Stemline Therapeutics, a Subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDU™ (elacestrant) as the First and Only Treatment Specifically Indicated for Patients...
Life Sciences Times
-
January 30, 2023
0
Pharma
Spesolimab meets primary and key secondary endpoint for prevention of generalized pustular psoriasis flares
Life Sciences Times
-
January 30, 2023
0
Pharma
Aptar Pharma Launches First Metal-Free Nasal Spray Pump, Meeting Growing Need for Highly Recyclable Packaging
Life Sciences Times
-
January 30, 2023
0
Pharma
Legend Biotech Announces Phase 3 CARTITUDE-4 Study of CARVYKTI® (ciltacabtagene autoleucel) Has Met Its Primary Endpoint in the Treatment of Patients with Relapsed and...
Life Sciences Times
-
January 27, 2023
0
Pharma
Bristol Myers Squibb Receives Positive CHMP Opinion for Reblozyl® (luspatercept) for Adult Patients with Anemia-Associated, Non-Transfusion-Dependent (NTD) Beta Thalassemia
Life Sciences Times
-
January 27, 2023
0
Pharma
BRUKINSA® (zanubrutinib) Receives Marketing Authorization for Chronic Lymphocytic Leukemia (CLL) and Marginal Zone Lymphoma (MZL) in Great Britain by MHRA
Life Sciences Times
-
January 19, 2023
0
Pharma
Amylyx Pharmaceuticals Announces Exclusive AMX0035 Distribution Agreement with Israel-Based Neopharm
Life Sciences Times
-
January 17, 2023
0
1
...
13
14
15
...
62
Page 14 of 62
Most Read
Alis Biosciences Launches Fund to Unlock $30 Billion in Trapped Capital from Struggling Biotech Firms
April 18, 2025
$2.25 Million Settlement Reached in Effexor XR® Class-Action Lawsuit Involving Teva Pharmaceuticals
April 18, 2025
Tempus Forms Advisory Board of Leading Physicians to Guide AI-Driven Precision Medicine
April 18, 2025
Beneath the biotech boom
April 17, 2025